Here is more recent news about a genomic analysis of prostate tissue from men in the study described below who developed prostate cancer. The research team, including some authors from the original study, tested for trends in gene expression according to the level of ejaculation frequency... keep reading

Research supports the anti-tumor effect of non-psychoactive CBD (cannabidiol), one of 100+ identified plant-derived cannabinoid compounds. For example, Kis et al. note that lab studies have shown a chemopreventive effect of cannabidiol in prostate cancer... keep reading

These days, it’s more important than even to protect your personal privacy and keep your information secure. Every day, we hear about identity theft, hackers, cybercrime, and security breaches. Just the thought of a thief or cyberattack penetrating not only our individual virus protection, firewalls, etc. but also those of our banking security or credit keep reading

Here it is, December of 2020. It’s been the Year of the Pandemic, and possibly also the Year of Increased Drinking. A September 29 ABC News story reported a sharp increase in U.S. alcohol consumption—especially among women—perhaps as a way to cope with feelings of isolation, depression and anxiety. keep reading

Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading

One of the most respected prostate cancer research facilities is the National Cancer Institute: The National Cancer Institute (NCI) is the federal government’s principal agency for cancer research and training. Established under the National Cancer Institute Act of 1937, NCI is part of the National Institutes of Health (NIH), one of 11 agencies that make keep reading

NOTE: The following is an update to a blog I posted in early 2020. Metformin red flag, December 2019 I have occasionally reported on studies that link a possible preventive effect against prostate cancer (PCa) with the common diabetes drug, metformin. In February 2020 I notified readers that the FDA had issued a Dec. 2019 keep reading

Roughly 1 out of 8 women will be diagnosed with invasive breast cancer (BCa). Screening mammograms are able to detect very early lesions before symptoms, such as a palpable lump, occur. Early detection facilitates a diagnosis during a period when the probability of treatment success is highest. Standard 2D mammograms are the most used method keep reading

The title of a paper published in the Journal of Physiology got my attention: “Acute High Intensity Interval Exercise Reduces Colon Cancer Cell Growth”. Questions immediately popped into my mind... keep reading

PLEASE NOTE: Recruitment for this study has closed and the study has concluded.   In keeping with our mission to serve men with prostate cancer, the Sperling Prostate Center (Delray Beach, FL) is assisting in a clinical research study to help develop a next-generation blood test to detect prostate cancer. This study is sponsored by keep reading